Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Gains from Sales and Divestitures: 2022-2025

  • Neogen's Gains from Sales and Divestitures rose 62.61% to $374,000 in Q2 2025 from the same period last year, while for May 2025 it was $374,000, marking a year-over-year increase of 62.61%. This contributed to the annual value of $374,000 for FY2025, which is 62.61% up from last year.
  • Per Neogen's latest filing, its Gains from Sales and Divestitures stood at $374,000 for Q2 2025, which was up 62.61% from $230,000 recorded in Q2 2024.
  • Over the past 5 years, Neogen's Gains from Sales and Divestitures peaked at $374,000 during Q2 2025, and registered a low of $25,000 during Q2 2022.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $230,000 (2024), whereas its average is $221,333.
  • Data for Neogen's Gains from Sales and Divestitures shows a peak YoY skyrocketed of 283.33% (in 2024) over the last 5 years.
  • Neogen's Gains from Sales and Divestitures (Quarterly) stood at $25,000 in 2022, then spiked by 140.00% to $60,000 in 2023, then skyrocketed by 283.33% to $230,000 in 2024, then surged by 62.61% to $374,000 in 2025.
  • Its last three reported values are $374,000 in Q2 2025, $230,000 for Q2 2024, and $60,000 during Q2 2023.